Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Prince

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 16, 2014
Models for predicting effective HIV chemoprevention in womenMelanie R Nicol, Cindi W Emerson, Heather M A Prince, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 16, 2013
Dolutegravir pharmacokinetics in the genital tract and colorectum of HIV-negative men after single and multiple dosingBenjamin N Greener, Kristine B Patterson, Heather M A Prince, et al.
HIV Medicine|February 26, 2013
Pharmacokinetics of two common antiretroviral regimens in older HIV-infected patients: a pilot studyJ B Dumond, J L Adams, H M A Prince, et al.
Plos One|December 31, 2016
Concentrations of Pro-Inflammatory Cytokines Are Not Associated with Senescence Marker p16INK4a or Predictive of Intracellular Emtricitabine/Tenofovir Metabolite and Endogenous Nucleotide Exposures in Adults with HIV InfectionBrian M Maas, Owen Francis, Katie R Mollan, et al.
Antiviral Therapy|October 31, 2018
Differential extracellular, but similar intracellular, disposition of two tenofovir formulations in the male genital tractJulie B Dumond, Stephen A Greene, Heather M A Prince, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 22, 2016
Cervicovaginal and Rectal Fluid as a Surrogate Marker of Antiretroviral Tissue Concentration: Implications for Clinical Trial DesignMackenzie L Cottrell, Heather M A Prince, Andrew Allmon, et al.
Journal of Intellectual Disability Research : JIDR|January 5, 2022
Latent profiles of autism symptoms in children and adolescents with Down syndromeD J Fidler, M A Prince, K Van Deusen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 10, 2019
Decreased Tenofovir Diphosphate Concentrations in a Transgender Female Cohort: Implications for Human Immunodeficiency Virus Preexposure ProphylaxisMackenzie L Cottrell, Heather M A Prince, Amanda P Schauer, et al.
The Journal of Infectious Diseases|February 27, 2016
A Translational Pharmacology Approach to Predicting Outcomes of Preexposure Prophylaxis Against HIV in Men and Women Using Tenofovir Disoproxil Fumarate With or Without EmtricitabineMackenzie L Cottrell, Kuo H Yang, Heather M A Prince, et al.
Science Translational Medicine|July 5, 2019
Heterogeneous antiretroviral drug distribution and HIV/SHIV detection in the gut of three speciesCorbin G Thompson, Elias P Rosen, Heather M A Prince, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 16, 2014
Models for predicting effective HIV chemoprevention in womenMelanie R Nicol, Cindi W Emerson, Heather M A Prince, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 16, 2013
Dolutegravir pharmacokinetics in the genital tract and colorectum of HIV-negative men after single and multiple dosingBenjamin N Greener, Kristine B Patterson, Heather M A Prince, et al.
HIV Medicine|February 26, 2013
Pharmacokinetics of two common antiretroviral regimens in older HIV-infected patients: a pilot studyJ B Dumond, J L Adams, H M A Prince, et al.
Plos One|December 31, 2016
Concentrations of Pro-Inflammatory Cytokines Are Not Associated with Senescence Marker p16INK4a or Predictive of Intracellular Emtricitabine/Tenofovir Metabolite and Endogenous Nucleotide Exposures in Adults with HIV InfectionBrian M Maas, Owen Francis, Katie R Mollan, et al.
Antiviral Therapy|October 31, 2018
Differential extracellular, but similar intracellular, disposition of two tenofovir formulations in the male genital tractJulie B Dumond, Stephen A Greene, Heather M A Prince, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 22, 2016
Cervicovaginal and Rectal Fluid as a Surrogate Marker of Antiretroviral Tissue Concentration: Implications for Clinical Trial DesignMackenzie L Cottrell, Heather M A Prince, Andrew Allmon, et al.
Journal of Intellectual Disability Research : JIDR|January 5, 2022
Latent profiles of autism symptoms in children and adolescents with Down syndromeD J Fidler, M A Prince, K Van Deusen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 10, 2019
Decreased Tenofovir Diphosphate Concentrations in a Transgender Female Cohort: Implications for Human Immunodeficiency Virus Preexposure ProphylaxisMackenzie L Cottrell, Heather M A Prince, Amanda P Schauer, et al.
The Journal of Infectious Diseases|February 27, 2016
A Translational Pharmacology Approach to Predicting Outcomes of Preexposure Prophylaxis Against HIV in Men and Women Using Tenofovir Disoproxil Fumarate With or Without EmtricitabineMackenzie L Cottrell, Kuo H Yang, Heather M A Prince, et al.
Science Translational Medicine|July 5, 2019
Heterogeneous antiretroviral drug distribution and HIV/SHIV detection in the gut of three speciesCorbin G Thompson, Elias P Rosen, Heather M A Prince, et al.
Pageof 4